Bioinformatics Market Research Report By Application (Genomics, Proteomics, Metabolomics, Translational Bioinformatics, Cheminformatics), By Deployment Type (On-Premise, Cloud-Based, Web-Based), By End-user (Academics, Pharmaceutical Companies, Biotechnology Companies, Research Organizations), By Product Type (Bioinformatics Tools, Bioinformatics Services, Bioinformatics Platforms), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Bioinformatics Market Summary

As per MRFR Analysis, the Bioinformatics Market was valued at 2.8 USD Billion in 2023 and is projected to reach 10.5 USD Billion by 2035, growing at a CAGR of 11.65% from 2025 to 2035. The market is driven by the increasing demand for genomic research, technological advancements in bioinformatics tools, and the rising incidence of chronic diseases.

Key Market Trends & Highlights

Key trends driving the Bioinformatics Market include advancements in technology and increasing demand for personalized medicine.

• Genomics segment valued at 0.947 USD Billion in 2024, expected to grow to 3.165 USD Billion by 2035.
• Proteomics segment projected to rise from 0.644 USD Billion in 2024 to 2.197 USD Billion by 2035.
• Cloud-based solutions gaining traction due to scalability and accessibility, enhancing research capabilities.

Market Size & Forecast

2023 Market Size: USD 2.8 Billion

2024 Market Size: USD 3.12 Billion

2035 Market Size: USD 10.5 Billion

CAGR (2025-2035): 11.65%

Largest Regional Market Share in 2024: North America.

Major Players

Key players include Genomatix Software, Bina Technologies, Thermo Fisher Scientific, Illumina, and Agilent Technologies.

Key Bioinformatics Market Trends Highlighted

Numerous important market factors are propelling the notable expansion of the Bioinformatics Market. The need for bioinformatics tools and systems that can evaluate complicated biological data has increased as a result of the growing emphasis on precision medicine.

A better understanding of genetic data is being made possible by the growing usage of next-generation sequencing technology, which is encouraging researchers and healthcare organizations to embrace bioinformatics platforms.

Additionally, the demand for effective drug discovery procedures and the growing incidence of chronic illnesses are driving the market's growth. Developments in artificial intelligence and machine learning present opportunities to be investigated in the global bioinformatics scene.

By improving data analytic skills, these technologies can enable more accurate interpretation of genetic data. Additionally, there is a synergistic potential for cooperation between pharmaceutical corporations and academic institutions, which might lead to creative solutions and more efficient research procedures.

Research becomes more effective and accessible worldwide as a result of the growing need for computational power and data storage, which also opens up opportunities for investment in cloud-based bioinformatics services.

The landscape of research and development has been shaped recently by developments like the integration of bioinformatics with other scientific fields including proteomics, metabolomics, and genomics. This multidisciplinary strategy is encouraging creativity and the creation of extensive databases that facilitate the understanding of biological data.

As stakeholders realize their vital role in advancing healthcare, the rising recognition of the significance of customized medicine is also promoting investments in bioinformatics solutions. As a result of these developments, the global bioinformatics industry is establishing itself as an essential part of the healthcare and life sciences industries.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Bioinformatics Market Drivers

Rising Demand for Personalized Medicine

The Bioinformatics Market is experiencing a significant growth trajectory driven by the increasing demand for personalized medicine. According to the National Institutes of Health, personalized medicine is projected to become a standard of care by 2030, especially in oncology and chronic diseases.

This shift hinges on the effective use of genetic information, fueling platforms for DNA sequencing and analysis. Organizations such as Illumina and Thermo Fisher Scientific are at the forefront of developing bioinformatics tools that analyze genomic data, indicating an upward trend in market needs.

The advancements in bioinformatics enable pharmaceutical companies to tailor therapies based on individual genetic profiles, which could lead to a reduction in trial and error approaches in treatment. As the global population ages and chronic diseases rise, the focus on personalized medications is anticipated to push the Bioinformatics Market to meet more sophisticated requirements.

Increase in Research and Development Activities

A pivotal driver for the Bioinformatics Market is the surge in Research and Development (R&D) activities across both academic and commercial sectors. Governments worldwide, including initiatives from the National Institutes of Health, allocate substantial funding for biotechnology research, projecting investments to reach nearly USD 38 billion by 2025.

This funding bolsters advancements in bioinformatics solutions that empower researchers to decode complex biological data. Furthermore, the increasing collaboration between tech companies and research institutes enhances the bioinformatics toolkit available to scientists.

With the rise of artificial intelligence and machine learning applications in biological research, such as collaborations formed by Microsoft and the Broad Institute, the innovation in bioinformatics tools is set to proliferate, positively influencing market growth. These initiatives are crucial as they deepen insights in genomics, leading to advancements in therapies and diagnostics.

Growing Incidence of Chronic Diseases

The rise in chronic diseases globally is a considerable market driver for the Bioinformatics Market. The World Health Organization reports that chronic diseases account for 71% of all deaths worldwide, with conditions such as diabetes and cancer on the rise.

This troubling statistic pushes healthcare organizations to integrate sophisticated bioinformatics tools to analyze patient data for better disease management and prevention strategies. Major pharmaceutical and biotechnology firms, such as Genentech and Amgen, are investing in bioinformatics capabilities to streamline drug development processes.

This integration not only enhances R&D efficacy but also leads to faster delivery of solutions to patients. The urgency to address chronic diseases is forcing healthcare systems to adopt bioinformatics as a standard practice, thereby boosting the demand within the market.

Bioinformatics Market Segment Insights

Bioinformatics Market Application Insights

The Bioinformatics Market focused on Application was poised for significant growth. A key driver of this growth was the increasing reliance on bioinformatics tools to analyze vast amounts of biological data. This sector encompassed several important areas: genomics, proteomics, metabolomics, translational bioinformatics, and cheminformatics.

Genomics emerged as a dominant area, grossing 1.12 USD Billion in 2024 and expected to reach 3.9 USD Billion by 2035, underscoring its extensive applications in personalized medicine and cancer research, which highly influence its valuation and market presence.

Following Genomics, Proteomics held a substantial market share, valued at 0.85 USD Billion in 2024, increasing to 2.9 USD Billion in 2035, driven by its critical role in drug discovery and development, which leveraged protein data for therapeutic advancements.

Metabolomics, although smaller in scale, showed significant promise, starting at 0.54 USD Billion in 2024 and projected to grow to 1.8 USD Billion by 2035, reflecting its growing importance in understanding metabolic processes and disease states.

Translational Bioinformatics provided a bridge between laboratory research and clinical practice with a valuation of 0.61 USD Billion in 2024 and an expected rise to 2.1 USD Billion in 2035, emphasizing its vital role in translating research findings into actionable clinical insights.

Cheminformatics remained at an emerging stage, currently valued at 0.0 USD Billion in 2024 and expected to reach 0.7 USD Billion by 2035, indicating its potential as researchers focus more on chemical data analysis related to drug compounds and materials.

Each of these areas contributed uniquely to the Bioinformatics Market, with investments directed towards enhancing their technological capabilities, thus driving both market growth and innovation.

The integration of artificial intelligence and machine learning in these applications is expected to further amplify their utility and efficacy, ultimately propelling the Bioinformatics Market revenue across various applications and domains.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Bioinformatics Market Deployment Type Insights

The Bioinformatics Market showcases significant growth within its Deployment Type segment, encompassing On-Premise, Cloud-Based, and Web-Based solutions. The shift towards Cloud-Based deployment is noteworthy, driven by the need for scalability and flexibility, enabling organizations to access vast bioinformatics data seamlessly.

On-Premise solutions maintain a strong presence, particularly in industries with stringent data security requirements, while Web-Based applications enhance user accessibility and convenience, appealing to a wider range of users.

The Bioinformatics Market statistics highlight the importance of these deployment types in addressing diverse customer needs and preferences, reflecting ongoing trends in digital transformation across the healthcare and biotechnology sectors.

As organizations increasingly prioritize data integration and analytical capabilities, the demand for efficient and accessible bioinformatics solutions will continue to grow, bolstering market expansion.

Furthermore, the importance of these deployment methods suggests opportunities for innovative services and technologies, ultimately driving advancements in market growth and enhancing the overall landscape of the Bioinformatics Market.

Bioinformatics Market End-user Insights

The Bioinformatics Market, focusing on the End-user segment, plays a pivotal role in driving innovation and advancement across various sectors. Within this segment, academic institutions form a crucial backbone, as they are essential in conducting research and developing new methodologies utilizing bioinformatics tools.

Pharmaceutical companies further amplify this growth, as they leverage bioinformatics for drug discovery and development, ensuring effective therapies are brought to market efficiently. Biotechnology companies utilize bioinformatics to enhance genetic engineering and synthetic biology initiatives, leading to a more sustainable and productive agricultural landscape.

Lastly, research organizations contribute significantly by applying bioinformatics techniques to analyze complex biological data sets, which can foster breakthroughs in health and disease management. The strong interrelation among these various End-users creates a dynamic ecosystem that supports the expanding Bioinformatics Market revenue.

Factors such as increased data availability, advancements in computational biology, and a rising demand for personalized medicine are fueling market growth, while challenges like data privacy and integration also need to be navigated carefully. Overall, the evolution of this sector reflects a robust commitment to innovation and scientific achievement on a global scale.

Bioinformatics Market Product Type Insights

Within this expansive market, the Product Type segmentation plays a crucial role in driving advancements in healthcare, agriculture, and personalized medicine. Leading the segment are Bioinformatics Tools, which offer essential capabilities for data analysis and interpretation, significantly contributing to research efficiency.

Bioinformatics Services are also vital, providing expert support that enables organizations to navigate complex data landscapes, enhancing research and development efforts. Meanwhile, Bioinformatics Platforms are becoming increasingly prominent by facilitating user-friendly interfaces for data management and analysis, creating an ecosystem that promotes innovation across various domains.

The Bioinformatics Market statistics reveal that the increasing emphasis on genomic research and the rising demand for personalized medicine serve as paramount growth drivers. However, challenges such as data privacy concerns and the need for skilled professionals persist.

Overall, opportunities in this market continue to flourish, supported by a global push for better healthcare outcomes and advancements in technology that drive market growth.

Bioinformatics Market Regional Insights

The Bioinformatics Market showed promising growth across various regions, reflecting a steady expansion in the field. North America was a significant player, valued at 0.947 USD Billion in 2024, and projected to grow to 3.176 USD Billion by 2035, largely due to its advanced Research and Development (R&D) capabilities and significant investments in biotechnology.

Europe followed closely, with a current valuation of 0.644 USD Billion and anticipated growth to 2.064 USD Billion over the same period, driven by strong governmental support for bioinformatics initiatives.

The Asia Pacific region, valued at 0.682 USD Billion in 2024, is expected to increase to 2.252 USD Billion by 2035, as emerging economies capitalize on technological advancements to enhance healthcare solutions.

Meanwhile, the Middle East and Africa market, starting at 0.697 USD Billion and forecasted to rise to 2.507 USD Billion, showcased a growing interest in bioinformatics due to increasing health concerns. South America, though smaller, was also on the rise with a value of 0.151 USD Billion in 2024, expected to reach 0.51 USD Billion by 2035, signaling potential opportunities for growth amidst various challenges.

Overall, each region exhibited unique drivers and market trends that contributed to the broader Bioinformatics Market expansion.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Bioinformatics Market Key Players and Competitive Insights

The Bioinformatics Market has emerged as a critical area at the intersection of biology, data science, and technological innovation, driven by the rapid advancements in genomics, proteomics, and other biological research domains.

This market encompasses a range of applications, including data analysis, biological data management, and the development of algorithms for data interpretation, which are crucial for various stakeholders such as pharmaceutical companies, research laboratories, and academic institutions.

Competitive dynamics within the bioinformatics landscape are shaped by ongoing technological advancements, increasing funding towards genomics research, and the growing demand for personalized medicine. As organizations strive to gain a competitive edge, investments in novel technologies and strategic collaborations to enhance research capabilities are prominent traits within the market.

Oxford Nanopore Technologies has positioned itself as a significant player in the Bioinformatics Market by innovating in DNA sequencing technology. The company offers portable, real-time sequencing solutions which have proven to be valuable for researchers aiming to conduct hands-on experiments with high mobility.

The strength of Oxford Nanopore Technologies lies in its unique technology that provides scalability and adaptability in various settings, making genomic data accessible to a broader range of applications. By enabling real-time data analysis, it enhances research productivity and facilitates timely decision-making in both clinical and academic environments.

The market presence of Oxford Nanopore Technologies is reinforced by its strong partnerships and collaborations within the research community, promoting extensive utilization of its products across multiple global markets.

Partek operates with a focused approach in the Bioinformatics Market, offering a suite of bioinformatics software designed to facilitate the analysis of genomic data.

Known for its comprehensive solutions, Partek's key products include Partek Flow and Partek Genomics Suite, which empower researchers to streamline their data analysis processes and gain valuable insights into biological phenomena.

The company’s strength is characterized by its user-friendly interfaces and robust data visualization capabilities that cater to researchers with varying levels of expertise. Partek maintains a strong market presence through strategic mergers and acquisitions, which enhance its technological offering and expand its customer base.

In addition, Partek provides extensive customer support and training programs, ensuring that users fully leverage its software solutions in their research pursuits. This focus on user engagement and innovation solidifies Partek's position in the competitive bioinformatics landscape within the global arena.

Key Companies in the Bioinformatics Market Include

• Oxford Nanopore Technologies


• Partek


• Thermo Fisher Scientific


• PerkinElmer


• Agilent Technologies


• BGI


• Lifegene


• Biorad


• DNAnexus


• Qiagen


• GeneDX


• Roche


• Illumina


• BioRad Laboratories

Bioinformatics Market Developments

After growing its genomic database tenfold since October 2024, Basecamp Research, a biotech company formed in the UK and run by Glen Gowers and Oliver Vince, revealed in May 31, 2025, that it was expanding its environmental DNA sequencing program.

According to the business, more than a million new species have been found in far-flung places like Antarctica and Malta, greatly improving AI protein-folding models and expanding the use of large serine recombinase (LSR) gene editing for intricate disease applications.

In a trade update published on January 13, 2025, Oxford Nanopore reported an 11% year-over-year increase in sales to £183 million and an 8.9% increase in share prices. The company attributed this growth to successful product launches, larger contracts, and projected break-even adjusted profitability by 2027 and positive cash flow by 2028.

In an effort to improve single-cell genomic research and boost profit margins with anticipated double-digit adjusted profit growth through 2027, Illumina and the Broad Institute announced a partnership to create CRISPR-based PerturbSeq sequencing kits on August 13, 2024.

Thermo Fisher Scientific unveiled Olink Reveal, a cutting-edge proteomics platform, in January 2025 with the goal of simplifying biomarker discovery processes and lowering testing expenses. Furthermore, Genedata announced in July 2024 that it had been acquired by Danaher Group, placing its business bioinformatics suite under a significant life sciences organization and setting it up for quicker worldwide adoption.

Bioinformatics Market Segmentation Insights

• 
  Bioinformatics Market Application Outlook
  
  
  
  • Genomics
  
  
  • Proteomics
  
  
  • Metabolomics
  
  
  • Translational Bioinformatics
  
  
  • Cheminformatics
  
  
  
  

• 
  Bioinformatics Market Deployment Type Outlook
  
  
  
  • On-Premise
  
  
  • Cloud-Based
  
  
  • Web-Based
  
  
  
  

• 
  Bioinformatics Market End-user Outlook
  
  
  
  • Academics
  
  
  • Pharmaceutical Companies
  
  
  • Biotechnology Companies
  
  
  • Research Organizations
  
  
  
  

• 
  Bioinformatics Market Product Type Outlook
  
  
  
  • Bioinformatics Tools
  
  
  • Bioinformatics Services
  
  
  • Bioinformatics Platforms
  
  
  
  

• 
  Bioinformatics Market Regional Outlook
  
  
  
  • North America
  
  
  • Europe
  
  
  • South America
  
  
  • Asia Pacific
  
  
  • Middle East and Africa
  
  
  
  

Report Attribute/Metric	Details
Market Size 2023	2.8(USD Billion)
Market Size 2024	3.12(USD Billion)
Market Size 2035	10.5(USD Billion)
Compound Annual Growth Rate (CAGR)	11.67% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Oxford Nanopore Technologies, Partek, Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, BGI, Lifegene, Biorad, DNAnexus, Qiagen, GeneDX, Roche, Illumina, BioRad Laboratories
Segments Covered	Application, Deployment Type, End-user, Product Type, Regional
Key Market Opportunities	Increased demand for personalized medicine, Advancements in genomic research, Growth in drug discovery processes, Rising adoption of cloud-based solutions, Integration of AI in bioinformatics
Key Market Dynamics	Increasing genomic research demand, Advancements in data analytics, Rising adoption of personalized medicine, Government funding initiatives, Growing prevalence of chronic diseases
Countries Covered	North America, Europe, APAC, South America, MEA